Slide 1: Financial and Operational Highlights
Annexure A Financial and Operational Highlights
Slide 2: FY 2020 Highlights
Annexure A FY 2020 Highlights 250 194.9 200 3% 158.2 153.4 150 RM Mn 100 26% 42.1 38.2 40% 50 33.9 25.3 30.6 18.4 0 Revenue EBITDA PBT FY2019 (12 mths) FY2019 (10 mths) FY2020 (10 mths)
Slide 3: FY 2020 Highlights
Annexure A FY 2020 Highlights 1.6 1.4 1.34 43% 1.2 1.2 1 RM 0.8 0.76 0.6 0.4 0% 0.2013 0.1678 0.1678 0.2 0 Dividend Basic EPS FY2019 (12 mths) FY2019 (10 mths) FY2020 (10 mths)
Slide 4: Key Operational Indicators
Annexure A Key Operational Indicators 5% 7% 0.1% 25,000 160,000 149,698 22,815 142,586 21,235 13.5% 140,000 20,000 18,648 122,384 122,491 120,000 16,128 100,000 15,000 80,000 10,000 60,000 40,000 5,000 20,000 0 0 Outpatients Inpatients FY2018 (12 mths) FY2019 (12 mths) FY2018 (12 mths) FY2019 (12 mt
Slide 5: Key Operational Indicators
Annexure A Key Operational Indicators 2 64 63 62 1.8 1.7 1.73 1.73 62 1.6 60 1.4 58 58 1.2 Days 1.72 % 56 1 54 0.8 54 0.6 52 0.4 50 0.2 48 0 Occupancy rates ALOS FY2018 (12 mths) FY2019 (12 mths) FY2018 (12 mths) FY2019 (12 mths) FY2019 (10 mths) FY2020 (10 mths) FY2019 (10 mths) FY2020 (10 mths)
Slide 6: Key Operational Indicators
Annexure A Key Operational Indicators 0% 9% 6.4 30 26 6.2 6.2 6.2 25 23.8 0% 6 20 18.8 18.8 RM Mn RM Mn 5.8 0% 15 5.6 5.5 5.5 10 5.4 5 5.2 0 5 Receivables (Corporate) Receivables (Cash) FY2018 (12 mths) FY2019 (12 mths) FY2018 (12 mths) FY2019 (12 mths) FY2019 (10 mths) FY2020 (10 mths) FY2019 (10 m
Slide 7: Capex incurred for the past years and for FY2021
Annexure A Capex incurred for the past 2 years and for FY2021 Total: 239.2 12.7 250 Total: 150.4 200 RM Mn Total: 77 20.1 150 213.6 100 6.6 106.8 34.9 50 35.5 23.5 12.9 0 FY2019 FY2020 FY2021 Recurring THKD Expansion JB Expansion
Slide 8: Comparison against Competitors
Annexure A Comparison against Competitors 1 - Represent average no. of admission per hospital 2 - Adjusted for doctors revenue portion 3 - This is per 2019 audited financial statement
Slide 9: Facts & Figures
Annexure A FACTS & FIGURES 235,622 112 924 Square Feet Specialist Consultants Employees 205 Established in Beds 52 Medical Specialties 2008 & Sub-specialties 142,586 4 years 2 years Accreditation by the RTAC Certification Outpatient Attendances in 2018 Malaysian Society for by DNV GL Quality in Heal
Slide 10: Achievements
Annexure A ACHIEVEMENTS 1st in Malaysia to offer ENT, Head and Neck CO2 Laser Treatment One of four private hospitals in Malaysia offering specialized Interventional Neuro-radiology services and Acute Stroke Response Team 1st Canon Aquilion One Genesis 640-slice CT System in Malaysia 1st Headache Cl
Slide 11: Awards
Annexure A AWARDS ● Best Quality Initiative IMTJ 2019, 2020 ● Diabetes Service Provider of the Year in Asia Pacific Global Health and Travel Awards 2018 ● ENT Service Provider of the Year in Asia Pacific Global Health and Travel Awards 2018 and 2019 ● Fertility Service Provider of the Year Global He
Slide 12: THKD Expansion
Annexure A THKD EXPANSION • Expected completion Q3 2021 847,430 Square Feet 500+ 9 1,150 Beds Delivery Suites Car Park Bays 11 2 154 Operating Catheterization Outpatient Theatres Labs Clinics
Slide 13: Site Progress Photos of THKD Expansion
Annexure A Site Progress Photos of THKD Expansion External building – Main Drop Area
Slide 14: Site Progress Photos of THKD Expansion
Annexure A Site Progress Photos of THKD Expansion External building Architectural Work in Progress
Slide 15: Jimmy Wong
Annexure A Jimmy Wong Group Chief Financial Officer TMC Life Sciences Berhad No. 11, Jalan Teknologi , PJU 5 Kota Damansara, 47810 Petaling Jaya, Selangor Darul Ehsan, Malaysia Tel | +603-6287 1111 Fax | +603-6287 1212